BIOCON LTD.

NSE : BIOCONBSE : 532523ISIN CODE : INE376G01013Industry : Pharmaceuticals & DrugsHouse : Private
BSE289.750.2 (+0.07 %)
PREV CLOSE ( ) 289.55
OPEN PRICE ( ) 292.00
BID PRICE (QTY) 289.60 (174)
OFFER PRICE (QTY) 289.80 (150)
VOLUME 158411
TODAY'S LOW / HIGH ( )289.00 293.25
52 WK LOW / HIGH ( )217.5 307
NSE289.800.2 (+0.07 %)
PREV CLOSE( ) 289.60
OPEN PRICE ( ) 292.00
BID PRICE (QTY) 289.80 (25)
OFFER PRICE (QTY) 289.85 (64)
VOLUME 5430090
TODAY'S LOW / HIGH( ) 288.95 293.25
52 WK LOW / HIGH ( )217.5 307.1
Exchange
Period From    
Period To    
Exchange Deal Date Client Name Tran Qty (000's) Trade Price () Value (Rs.in Lakhs) Close Price ()

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.